Minimal but essential doses of immunosuppression: a more realistic approach to improve long-term outcomes for pediatric living-donor liver transplantation.
1 Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto, Japan (Ohe, Nafady-Hego, Uemoto, Koshiba) 2 Department of Experimental Pathology; Institute for Frontier Medical Science; Kyoto University; Kyoto, Japan (Li, Sakaguchi) 3 Department of Ubiquitous Health Informatics; Graduate school of Medicine; The University of Tokyo; Tokyo, Japan (Kayo) 4 Transplantation Research Immunology Group; Nuffield Department of Surgery; University of Oxford; John Radcliffe Hospital; Headington, Oxford, United Kingdom (Wood) 5 Department of Surgery & Medicine; University of Cambridge; United Kingdom and National University of Singapore, Singapore (Calne).Transplantation (Impact Factor: 3.78). 04/2011; 91(7):808-10. DOI:10.1097/TP.0b013e31820f07de
- [show abstract] [hide abstract]
ABSTRACT: Regulatory cells prevent graft loss to acute rejection and induce tolerance, possibly by promoting Th2 deviation. Th2 cytokines stimulate B cells, which cause alloantibody-mediated chronic rejection. We searched to determine whether regulatory cell-mediated tolerance protects or not against chronic rejection. Heart transplantation (Htx) was performed using RA (RT1P) and PVG (RT1c) rats as donor and recipients. Donor-specific blood transfusion (DSBT) was given on preTx day 12. Secondary grafts were implanted at day 100. Splenocytes were transferred from tolerant rats (and controls) into lightly irradiated (450 rad) naive PVG, which received RA Htx. Primary Htx were investigated for the development of vascular occlusion (VO), the production of Th1/Th2 intragraft cytokines, and for the nature of graft infiltrate as well as for endothelial deposition of immunoglobulin (Ig)G isotypes and complement (C3) binding. Results were compared with rejecting controls (no DSBT) and syngeneic Htx. RA Htx were rejected within 10 days (8, 9, 10x4). PreTx DSBT prolonged primary Htx survival indefinitely (>140 days) with acceptance of secondary donor-specific (but not third-party) grafts (P<0.001). Naive irradiated PVG rats given splenocytes from tolerant rats but not from controls accepted RA Htx, showing the existence of regulatory cells in allograft acceptors. Despite being tolerant, DSBT-treated rats displayed typical features of chronic rejection at day 90 (VO=77%; P<0.001 vs. VO=4% in syngeneic rats). An overt Th2 deviation, particularly intragraft production of interleukin (IL)-4, was observed at day 30. Simultaneously to this Th2 deviation, B cells emerged in the grafts and endothelial deposition of IgG1 (Th2 dependent) and C3 binding were observed. Regulatory cells that prevent graft loss to acute rejection in primary and secondary grafts do not protect against the development of chronic rejection.Transplantation 08/2003; 76(3):588-96. · 3.78 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.